Picture of Celon Pharma SA logo

CLN Celon Pharma SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Annual cashflow statement for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
R2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line29.711.9-5.59-15.1-36.4
Depreciation
Non-Cash Items0.101-0.5040.7673.63-4.62
Unusual Items
Other Non-Cash Items
Changes in Working Capital-18.8-37.144.814.1-7.73
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities28.2-5.0571.744-4.7
Capital Expenditures-67.5-65-99.5-41.4-33.9
Purchase of Fixed Assets
Other Investing Cash Flow Items-5.28-2.7846.2-79.72.43
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-72.7-67.7-53.3-121-31.5
Financing Cash Flow Items0.098-0.174-0.586-14.3-1.5
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-8.85-8.524.25181-28.7
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-53.4-81.322.7104-64.9